To enable the analysis of anything, by anyone, anywhere.
Oxford Nanopore Technologies, founded in 2005 as a University of Oxford spin-out, develops a novel generation of DNA and RNA sequencing technology. Its devices — from pocket-sized MinION to high-throughput PromethION — enable real-time, long-read sequencing in any environment. The company, listed on the London Stock Exchange (ONT), employs over 1,300 staff and sells to more than 120 countries across research, clinical, and applied markets.